NCT06733350View on ClinicalTrials.gov

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

PHASE4RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

January 15, 2029

Study Completion Date

January 15, 2029

Conditions
Localized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8
Interventions
PROCEDURE

Biopsy of Prostate

Undergo prostate biopsy

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Patient Observation

Undergo standard AS

OTHER

Questionnaire Administration

Ancillary studies

DRUG

Therapeutic Testosterone

Given via injection, gel, lotion, or transdermal patch

Trial Locations (1)

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT06733350 - Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance | Biotech Hunter | Biotech Hunter